New tool predicts nerve damage risk from breast cancer treatment

FHS
July 8, 2024
7:46 pm

Many women treated for breast cancer using taxanes, a type of cytostatic drug, often experience side effects in the nervous system.

Medtronic Expands AI-Driven Partnership with Cosmo Pharmaceuticals

What You Should Know: – Medtronic announced an expanded AI partnership with Cosmo Pharmaceuticals NV, a pharmaceutical company, to further advance AI-powered solutions in the

December 12, 2023

Devoted Health’s losses in Medicare Advantage persist

Devoted Health has been one of the most prominent health insurance and provider startups of the past decade — founded and overseen by several alumni

February 5, 2024

The biotech news roundup to start your week

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Morning! Today, we see even

November 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.